Solaris Pharma Receives Approval for First Generic Version of Clindagel® (clindamycin phosphate EQ 1%)
Solaris Pharma Receives Approval for First Generic Version of Clindagel Solaris Pharma Receives Approval for…
Month: August 2021
Spectral Medical Announces its Participation at Upcoming Investor Conferences
TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of COVID-19 Booster Vaccine
Based on successfully achieving certain milestones primarily related to the execution of a Phase 3…
Athira Pharma to Present on ERP P300 as a Direct, Functional, Non-Invasive Biomarker at the Annual Biomarkers for Alzheimer’s Disease Summit
BOTHELL, Wash., Aug. 23, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late…
Aleafia Health Announces Closing of $10 Million Credit Facility
Credit Facility provides financial capacity to pursue accretive growth opportunities New debt lender increases financial…
Acerus Announces Participation in HC Wainwright Conference
TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP;…
Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids
By achieving commercial scale production of CBG, the companies are on track to enable access…
AnPac Bio Successfully Completes Major PreClinical Study, Files with National Medical Products Administration (NMPA) for Registration Testing of Its Multi-Cancer CDA Device
PHILADELPHIA, Aug. 23, 2021 (GLOBE NEWSWIRE) — via Investor Wire – AnPac Bio-Medical Science Co.,…
Todos Medical CEO to Appear on Fox Business Network Varney & Company Today at 11:40am to Discuss the Company’s Launch of cPass Neutralizing Antibody Testing for Monitoring COVID-19 Immunity
New York, NY, and Tel Aviv, ISRAEL, Aug. 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos…
Foghorn Therapeutics Announces First Patient Dosed in First-in-Human Clinical Trial of FHD-609
FHD-609 is a first-in-class, highly potent and selective protein degrader of BRD9 Foghorn’s first protein…
Update — Pharma Two B Appoints Jeffrey Berkowitz as Chairman of its Board of Directors
REHOVOT, Israel, Aug. 23, 2021 (GLOBE NEWSWIRE) — Pharma Two B Ltd., a privately held…
Pfizer to Acquire Trillium Therapeutics Inc.
Proposed acquisition strengthens Pfizer’s category leadership in Oncology with addition of next-generation, investigational immuno-therapeutics for…
Affimed to Report Second Quarter 2021 Financial Results & Corporate Update on September 8, 2021
HEIDELBERG, Germany, Aug. 23, 2021 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical stage…
Pax8 Celebrated with Three XCellence Awards at XChange+ August 2021
DENVER, Aug. 23, 2021 (GLOBE NEWSWIRE) — Pax8, the best place for IT professionals to…
Onit Named to the Inc. 5000 for the Sixth Consecutive Year
List of America’s Fastest-Growing Private Companies Ranks Onit in Top 25% with Three-Year Revenue Growth…
Applied Launches Fully Browser-Native Version of Applied Epic
New, open architecture of Applied Epic to enable greater choice, flexibility and operational efficiency via…
Applied Expands Epic Quotes to Support Commercial Lines
Industry’s first integrated small commercial quoting application supported by the IVANS Distribution Platform to automate…
Supply Chain Risk Management by Everstream Analytics Now Available on SAP® Store
Solution provides guidance on the likely timeliness and condition of a planned shipment before it…
FortiGuard Labs Reports Tenfold Increase in Ransomware
Public and Private Sector Actions Are Gaining Momentum in Disrupting Cybercrime Supply Chains Growth in…
Swedish National Broadcaster SVT Chooses Avid Software Subscription for TV News and Programming Production Workflows
Enterprise-wide subscription for MediaCentral platform and creative tools adds flexibility and capabilities for large and…